Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

9 In 2005, Masimo introduced rainbow ® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively ...

Anna Morgan, MD, study's co-lead author, medical director of the ... have integrated pulse oximetry into the routine home management of patients with COVID-19, but there's been scant evidence ...